Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Delayed Quote. Delayed  - 05/04 05:35:29 pm
70.13 EUR   -2.12%
05/04 Sanofi sees 'strong strategic' fit with U.S. Medivation
05/04 SANOFI : Annual General Shareholder Meeting of May 4, 2016
05/04 SANOFI : Annual General Shareholder Meeting of May 4, 2016
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/08/2012 | 07:44am CEST

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.

MAIN FACTS:

- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at inti.landauro@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : SANOFI
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on SANOFI
05/04 Sanofi sees 'strong strategic' fit with U.S. Medivation
05/04 SANOFI : Annual General Shareholder Meeting of May 4, 2016
05/04 SANOFI : Annual General Shareholder Meeting of May 4, 2016
05/04DJMicrosoft Aims to Wrangle Data for Office Teams With SharePoint Revamp
05/03DJPfizer Has Approached Medivation About Potential Acquisition -Reuters
05/03 MEDIVATION : Board rejects Sanofi’s unsolicited proposal
05/03 SANOFI : Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2..
05/02 SANOFI : Comments on Medivation's Rejection of acquisition Proposal
05/01 BRIEF : Sanofi girds for another fight
04/30 SANOFI : Zealand reports Lyxumia royalty revenue for Q1 2016 and submission by S..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials